EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Research progress of norcantharidin nanodrugs for tumor treatment

Zhi-Yu Xia, Hao-Liang Peng, Yong You, Lu Zhang, Qiu-Ying Deng, Lei Zhou, Si-Lin Chen, Xin-Yi Guo, Jing-Xing Guo, Dong-Bing Cheng

Nanoscale · 2025 · 17 (30) · 17508-17528

DOI: 10.1039/d5nr01530h ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nanoscale, 2025. Verfasst von Zhi-Yu Xia und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Chemical Engineering & Life Science, Wuhan University of Technology, No. 122 Luoshi Road, Wuhan, 430070, PR China. jxguo@whut.ed…. Hauptthemen laut MEDLINE: Bridged Bicyclo Compounds, Heterocyclic, Neoplasms, Antineoplastic Agents, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 126 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review summarizes recent advances in norcantharidin (NCTD)-based nanomedicines for tumor therapy, focusing on four major research areas: prodrug modification, encapsulation and delivery, immunotherapy, and combination therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bridged Bicyclo Compounds, HeterocyclicNeoplasmsAntineoplastic AgentsNanoparticlesHumansAnimalsProdrugsImmunotherapyDrug Delivery Systems

Substanzen

norcantharidinBridged Bicyclo Compounds, HeterocyclicAntineoplastic AgentsProdrugs

Autor:innen und Institutionen

  • School of Chemistry, Chemical Engineering & Life Science, Wuhan University of Technology, No. 122 Luoshi Road, Wuhan, 430070, PR China. jxguo@whut.edu.cn.
  • Jingmen Central Hospital, No. 168 Xiangshan Road, Duodao District, Jingmen, 448000, PR China.
  • Jinmen Central Hospital Affiliated to Jingchu University of Technology, No. 168 Xiangshan Road, Duodao District, Jingmen, 448000, PR China.
  • Hubei Longzhong Laboratory, Wuhan University of Technology Xiangyang Demonstration Zone, Xiangyang 441000, Hubei, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xia, Z. Y., Peng, H. L., You, Y., Zhang, L., Deng, Q. Y., Zhou, L., Chen, S. L., Guo, X. Y., Guo, J. X., & Cheng, D. B. (2025). Research progress of norcantharidin nanodrugs for tumor treatment. Nanoscale, 17(30), 17508-17528. https://doi.org/10.1039/d5nr01530h

Vancouver

Xia ZY, Peng HL, You Y, Zhang L, Deng QY, Zhou L, et al. Research progress of norcantharidin nanodrugs for tumor treatment. Nanoscale. 2025;17(30):17508-17528. doi:10.1039/d5nr01530h

BibTeX
@article{Xia2025,
  author = {Xia, Zhi-Yu and Peng, Hao-Liang and You, Yong and Zhang, Lu and Deng, Qiu-Ying and Zhou, Lei and Chen, Si-Lin and Guo, Xin-Yi and Guo, Jing-Xing and Cheng, Dong-Bing},
  title = {Research progress of norcantharidin nanodrugs for tumor treatment},
  journal = {Nanoscale},
  year = {2025},
  volume = {17},
  number = {30},
  pages = {17508--17528},
  doi = {10.1039/d5nr01530h}
}
Kostenlos starten →